Latest Global Markets News

Page 1 of 49
Citigroup Global Markets Australia has announced the record and ex-dividend dates for a fully franked dividend on MFG ordinary shares and its linked CitiFirst Self-Funding Instalment MINI, with dividends directed to reduce outstanding loan amounts.
Claire Turing
Claire Turing
20 Feb 2026
London City Equities Limited reported a 38% revenue increase and a $5.6 million capital gain from asset sales, while boosting liquidity to nearly 60% of its portfolio and raising dividends amid a cautious investment outlook.
Claire Turing
Claire Turing
20 Feb 2026
Diversified United Investment Limited reported a modest profit increase for the half year ending December 2025, alongside a stable dividend and a proposed merger with Australian United Investment Company Limited.
Victor Sage
Victor Sage
20 Feb 2026
Charter Hall Group has reported a strong first half for FY26, with operating earnings surging 21.6% and record equity inflows driving funds under management to $92.2 billion. The group has upgraded its full-year earnings guidance, signalling confidence amid ongoing market volatility.
Eva Park
Eva Park
19 Feb 2026
Evion Group has secured formal notice from Madagascar’s Mines Ministry that its Maniry Graphite Project permits have passed technical assessment and are set for expedited approval, marking a key step towards production.
Maxwell Dee
Maxwell Dee
19 Feb 2026
Orthocell has secured a $3 million R&D tax refund, lifting its cash reserves to nearly $50 million and reinforcing its financial strength as it pushes commercialisation of its nerve repair product Remplir™ across key global markets.
Ada Torres
Ada Torres
18 Feb 2026
Hearts and Minds Investments Limited reported a dramatic 97% drop in half-year comprehensive income to $3 million, with a largely flat investment portfolio and a significant write-down of Corporate Travel Management shares. Despite this, the company declared a fully franked interim dividend of 9.5 cents per share.
Claire Turing
Claire Turing
18 Feb 2026
Telix Pharmaceuticals has lodged a European marketing authorization application for TLX101-Px, a novel PET imaging agent targeting glioma brain cancer, aiming to enhance diagnostic precision and patient access across major European markets.
Ada Torres
Ada Torres
18 Feb 2026
Citigroup Global Markets Australia has announced key dividend dates for CBA CitiFirst Self-Funding Instalment MINIs, aligning with Commonwealth Bank ordinary shares and adjusting outstanding loan amounts for holders.
Claire Turing
Claire Turing
17 Feb 2026
Morphic Ethical Equities Fund Limited reported a half-year profit after tax of $1.26 million for December 2025, declaring a fully franked 1 cent dividend and continuing its share buy-back program.
Claire Turing
Claire Turing
17 Feb 2026
Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Citigroup Global Markets Australia has announced a fully franked dividend of $2.35 per instalment for the CBA CitiFirst Self-Funding Instalments, alongside key loan amount adjustments and upcoming trading dates.
Victor Sage
Victor Sage
17 Feb 2026